logoTry Persana

FibroGen, Inc. - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about FibroGen, Inc. including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

FibroGen, Inc. company logo

Committed to being a place where our people and science thrive.

FibroGen, Inc. is a biopharmaceutical company dedicated to discovering and developing a pipeline of first-in-class therapeutics to address unmet medical needs in various areas including oncology and anemia.

HeadquartersSan Francisco, CA, United States
Team size201-500
Founded1993

What is FibroGen, Inc.? - Company Overview & Details

FibroGen, Inc. is FibroGen, Inc. is a biopharmaceutical company dedicated to discovering and developing a pipeline of first-in-class therapeutics to address unmet medical needs in various areas including oncology and anemia. Founded in 1993, the company is headquartered in San Francisco, CA, United States.

Who Founded FibroGen, Inc.?

FibroGen, Inc. was founded by Tom Neff.

Who are the Key Executives at FibroGen, Inc.? - Leadership Team

FibroGen, Inc. is led by experienced executives in key positions:

FibroGen, Inc. Company Details & Key Information

Where is FibroGen, Inc. located?

FibroGen, Inc. is headquartered in San Francisco, CA, United States.

How many employees does FibroGen, Inc. have?

FibroGen, Inc. has 201-500 employees.

When was FibroGen, Inc. founded?

FibroGen, Inc. was founded in 1993.

How much funding has FibroGen, Inc. raised?

FibroGen, Inc. has raised undisclosed amount across 11 funding rounds.

N/A
Total Funding Raised
11
Funding Rounds
N/A
Latest Round

Who are the key investors in FibroGen, Inc.?

FibroGen, Inc. is backed by 1 key investors including AstraZeneca. These investors focus on Biotechnology, Pharmaceuticals sectors.

FibroGen, Inc. Investor Overview

1
Key Investors
2
Focus Areas
1
Notable Investments

Complete List of FibroGen, Inc. Investors

AstraZeneca

A multinational pharmaceutical and biotechnology company.

Investment Focus
Biotechnology
Pharmaceuticals
Notable Portfolio Companies
Acquisition of FibroGen's Chinese subsidiary

What sectors do FibroGen, Inc. investors focus on?

The investors backing FibroGen, Inc. primarily focus on Biotechnology, Pharmaceuticals sectors.

Biotechnology
Pharmaceuticals

Featured Investor: AstraZeneca

AstraZeneca

A multinational pharmaceutical and biotechnology company.

Notable Investments: Acquisition of FibroGen's Chinese subsidiary

What are FibroGen, Inc.'s future plans?

FibroGen, Inc. FibroGen is focused on advancing its clinical pipeline and pursuing strategic partnerships for drug development.

FibroGen, Inc. Strategic Outlook

Strategic Focus
Defined
1
Key Challenges
1
Growth Opportunities

What challenges does FibroGen, Inc. face?

FibroGen, Inc. has identified 1 key challenges that need to be addressed for continued growth and success.

Key Challenges for FibroGen, Inc.

1

Limited pipeline due to recent clinical trial failures

What opportunities does FibroGen, Inc. have?

FibroGen, Inc. has identified 1 key opportunities for growth and market expansion.

Growth Opportunities for FibroGen, Inc.

1

Development of innovative therapies in oncology and anemia

FibroGen, Inc. Strategic Position Summary

Key Focus Areas

FibroGen, Inc. is addressing 1 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 1 key opportunities for expansion and growth.

What are the latest news about FibroGen, Inc.?

FibroGen, Inc. has 2 recent news updates covering key business developments and market activities.

FibroGen, Inc. News Overview

2
Recent Articles
Active
Media Coverage
2024-12-16
Latest Update

What is FibroGen, Inc. in the news for?

FibroGen, Inc. is currently featured in news for FibroGen, Inc. hired David DeLucia as Chief Financial Officer on Dec 16th '24. and other significant business developments.

Recent News Articles About FibroGen, Inc.

Article 1
2024-12-16

FibroGen, Inc. hired David DeLucia as Chief Financial Officer on Dec 16th '24.

FibroGen announces the appointment of David DeLucia as Chief Financial Officer.

globenewswire.com
Read News
Article 2
2024-08-06

FibroGen, Inc. decreased headcount by 127 on Aug 9th '24.

FibroGen is laying off 127 employees based at its headquarters due to disappointing clinical trial results.

sfexaminer.com
Read News

FibroGen, Inc. FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about FibroGen, Inc. including information about founders, CEO, funding history, investors, headquarters location, and company details. 11 frequently asked questions covering key information about the company.

FibroGen, Inc. Questions & Answers - Company Information

Q1

What is FibroGen, Inc.?

FibroGen, Inc. is a biopharmaceutical company dedicated to discovering and developing a pipeline of first-in-class therapeutics to address unmet medical needs in various areas including oncology and anemia.

Q2

Who founded FibroGen, Inc.?

FibroGen, Inc. was founded by Tom Neff.

Q3

Who are the investors in FibroGen, Inc.?

FibroGen, Inc.'s key investors include AstraZeneca.

Q4

Where is FibroGen, Inc. headquartered?

FibroGen, Inc. is headquartered in San Francisco, CA, United States.

Q5

When was FibroGen, Inc. founded?

FibroGen, Inc. was founded in 1993.

Q6

How many employees does FibroGen, Inc. have?

FibroGen, Inc. has 201-500 employees.

Q7

What does the company do?

FibroGen, Inc. is a biopharmaceutical company dedicated to discovering and developing a pipeline of first-in-class therapeutics to address unmet medical needs in various areas including oncology and anemia.

Q8

Who are the investors?

AstraZeneca

Q9

What are the challenges?

Limited pipeline due to recent clinical trial failures

Q10

What are the opportunities?

Development of innovative therapies in oncology and anemia

Q11

Latest news?

FibroGen announces the appointment of David DeLucia as Chief Financial Officer. FibroGen is laying off 127 employees based at its headquarters due to disappointing clinical trial results.

More Information About FibroGen, Inc.

For additional details about FibroGen, Inc., including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.